p27/kipI expression in normal epithelium, benign and neoplastic breast lesions

Journal of Pathology

Volumn 196, Issue 1, 2002, Pages 26-31

  De Paola, Franca ^a   Maria Vecci, Anna ^a   Maria Granato, Anna ^a   Liverani, Marilena ^b   Monti, Franco ^c   Maria Innoceta, Anna ^c   Gianni, Lorenzo ^c   Saragoni, Luca ^b   Ricci, Monica ^c   Falcini, Fabio ^b   Amadori, Dino ^b   Volpi, Annalisa ^b  

^a ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

^b MORGAGNI PIERANTONI HOSPITAL   (Italy)

^c INFERMI HOSPITAL   (Italy)

Author keywords

Benign breast lesions; Breast carcinoma; p27 kip1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27; CDKN1B; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASES; ENZYME INHIBITOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; BREAST EPITHELIUM; BREAST FIBROADENOMA; BREAST HYPERPLASIA; BREAST TUMOR; CANCER INVASION; CARCINOMA IN SITU; CELL COUNT; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; BREAST; CELL CULTURE; ENZYME IMMUNOASSAY; EPITHELIUM CELL; FIBROADENOMA; METABOLISM; PATHOLOGY;

BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASES; DISEASE PROGRESSION; ENZYME INHIBITORS; EPITHELIAL CELLS; FIBROADENOMA; IMMUNOENZYME TECHNIQUES; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0036006675     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1011     Document Type: Article

References (37)

1. Creative blocks: Cell-cycle checkpoints and feedback controls
2. Activation of the various cyclin/cdc2 protein kinases
3. G1 phase progression: Cycling on cue
4. G1 control in mammalian cells
5. Inhibitors of mammalian G1 cyclin-dependent kinases
6. Principles of CDK regulation
7. Cloning of p27/kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
8. Translation control of p27/kip1 accumulation during the cell cycle
9. Targeting ubiquitin-mediated degradation for proliferation inhibitors
10. Accumulation of the cyclin-dependent kinase inhibitor p27/kip1 and the timing of oligodendrocyte differentiation
11. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27/kip1
12. E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27/kip1 (KIP1)
13. kip1
14. kip1 protein: Prognostic implications in primary breast cancer
15. 1a,b) invasive breast carcinomas
16. kip1 and apoptosis in human breast cancer
17. kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma
18. kip1 in node-positive breast cancer
19. Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients
20. Reduced expression of p27/Kip 1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation
21. kip1 and cyclin E, alone and in combination, correlates with survival in young breast cancer patients
22. Expression of proliferation and apoptosis-related proteins in usual ductal hyperplasia of the breast
23. Epithelial hyperplasia
24. A prospective study of the development of breast cancer in 16,692 women with benign breast disease
25. Techniques of clinical cytology
26. Establishment and characterization of a new cell line from primary human breast carcinoma
27. Cancer cell cycles
28. kip1 expression in endocrine and other tumors
29. kip1 in epithelial dysplasia and carcinoma of the oral cavity
30. kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer
31. kip1 in multistage colorectal carcinogenesis
32. kip1 and degree of malignancy in human breast and colorectal cancer
33. Prognostic significance of biologic markers in node-negative breast cancer patients: A prospective study
34. Loss of altered subcellular localization of p27 in Barrett's associated adenocarcinoma
35. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation
36. kip1 in human breast cancers
37. American Society of Clinical Oncology: Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer